Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
Davis Todd C reported 1 trade in Ligand Pharmaceuticals Incorporated shares (Form 4)
Traded Jun 30, 2026 · Filed Jul 6, 2026
On Jun 30, 2026, Davis Todd C (Director, Chief Executive Officer) reported 1 trade in Ligand Pharmaceuticals Incorporated shares at US$160.71 for US$21,214, leaving 199,513 shares. Filed Jul 6, 2026 (Form 4).
- Shares
- 132 shares
- Price
- US$160.71
- Value
- US$21,214
- Holding after
- 199,513 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | Other | 132 | US$160.71 | 199,513 | Direct |